KC
CLB icon

Kingfisher Capital’s Core Laboratories CLB Stock Holding History

Kingfisher Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,835
Closed -$1.25M – 131
2018
Q3 		$1.25M Buy
10,835
+55
+0.5% +$6.21K 0.67% 50
2018
Q2 		$1.36M Sell
10,780
-1,090
-9% -$133K 0.86% 38
2018
Q1 		$1.28M Buy
11,870
+61
+0.5% +$6.75K 0.82% 47
2017
Q4 		$1.29M Sell
11,809
-163
-1% -$16.3K 0.82% 48
2017
Q3 		$1.18M Sell
11,972
-218
-2% -$21.1K 0.78% 53
2017
Q2 		$1.24M Buy
12,190
+368
+3% +$39.7K 0.84% 51
2017
Q1 		$1.37M Sell
11,822
-1,134
-9% -$132K 0.99% 40
2016
Q4 		$1.55M Sell
12,956
-641
-5% -$71K 1.17% 26
2016
Q3 		$1.53M Sell
13,597
-542
-4% -$62.4K 1.06% 32
2016
Q2 		$1.75M Sell
14,139
-515
-4% -$62.2K 1.16% 31
2016
Q1 		$1.65M Buy
14,654
+625
+4% +$64.9K 1.03% 38
2015
Q4 		$1.53M Buy
+14,029
New +$1.61M 0.9% 41

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Kingfisher Capital's CLB Position: Q4 2018 in Review

Kingfisher Capital sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 10,835 shares — an estimated $1.25M sold.

Kingfisher Capital first reported a position in CLB in Q4 2015 and held it in 12 quarters. The position peaked at $1.75M in Q2 2016. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Kingfisher Capital reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Kingfisher Capital sold 10,835 Core Laboratories shares in Q4 2018, an estimated $1.25M.
  • Kingfisher Capital first reported a position in Core Laboratories in Q4 2015 and held it in 12 quarters.
  • Kingfisher Capital's Core Laboratories position peaked at $1.75M in Q2 2016.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Kingfisher Capital's 13F filing for Q4 2018, filed 13 Feb 2019.